To the best of our knowledge, this is the first report on the crosstalk between ERβ2 and mutant p53 to upregulate FOXM1 expression, proliferation, and therapeutic resistance in HGSOC cells and patient tumor tissues. Here, TP53 is linked to neoplasm.